Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-06 Purchase |
2023-01-10 5:14 pm |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,853,000 | $2.21 | $4,095,130 | 6,144,881 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-19 Option Award |
2025-02-21 5:57 pm |
N/A 2035-02-18 |
Werewolf Therapeutics Inc. | HOWL | Singhal Anil K. Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:51 pm |
N/A 2034-12-31 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
131,900 | $0 | 131,900 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:44 pm |
N/A 2034-12-31 |
Werewolf Therapeutics Inc. | HOWL | Trost Timothy W. Chief Financial Officer |
210,358 | $0 | 210,358 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:44 pm |
N/A 2034-12-31 |
Werewolf Therapeutics Inc. | HOWL | Isaacs Randi Chief Medical Officer |
255,651 | $0 | 255,651 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:43 pm |
N/A 2034-12-31 |
Werewolf Therapeutics Inc. | HOWL | Karunatilake Chulani Chief Technology Officer |
303,129 | $0 | 303,129 (Direct) |
View |
| 2025-01-02 Option Award |
2025-01-06 5:41 pm |
N/A 2034-12-31 |
Werewolf Therapeutics Inc. | HOWL | HICKLIN DANIEL J See Remarks |
778,342 | $0 | 778,342 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:56 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
17,500 | $0 | 17,500 (Indirect) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:52 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | DiRocco Derek Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:49 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:48 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | Atkins Michael B. Director |
6,723 | $0 | 6,723 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:46 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | Chatterjee Meeta Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:45 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:45 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2024-05-24 Option Award |
2024-05-24 7:44 pm |
N/A 2034-05-23 |
Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-04 7:19 pm |
N/A 2034-01-03 |
Werewolf Therapeutics Inc. | HOWL | Atkins Michael B. Director |
35,000 | $0 | 35,000 (Direct) |
View |
Ownership |
2024-01-04 7:13 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | Atkins Michael B. Director |
0 | $0 | 14,419 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:40 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | Trost Timothy W. Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:37 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
131,900 | $0 | 131,900 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:33 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | Isaacs Randi Chief Medical Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:30 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | Karunatilake Chulani Chief Technology Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:30 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-01-02 Option Award |
2024-01-04 4:26 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | HICKLIN DANIEL J See Remarks |
435,000 | $0 | 435,000 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 5:09 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
13,200 | $0 | 13,200 (Indirect) |
View |
| 2023-06-21 Option Award |
2023-06-23 5:07 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | Morrison Briggs Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:53 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | EVNIN LUKE Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:52 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | Lazarus Alon Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:52 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | DiRocco Derek Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:49 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | Chatterjee Meeta Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-06-21 Option Award |
2023-06-23 4:48 pm |
N/A 2033-06-20 |
Werewolf Therapeutics Inc. | HOWL | Sherman Michael A. Director |
13,200 | $0 | 13,200 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:38 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | HICKLIN DANIEL J See Remarks |
295,500 | $0 | 295,500 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:36 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Lubman Ellen Chief Business Officer |
86,200 | $0 | 86,200 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:36 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
115,900 | $0 | 115,900 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:35 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Karunatilake Chulani Chief Technology Officer |
103,600 | $0 | 103,600 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:35 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Trost Timothy W. Chief Financial Officer |
102,800 | $0 | 102,800 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:34 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Leonard Reid Chief Operating Officer |
93,600 | $0 | 93,600 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:32 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Isaacs Randi Chief Medical Officer |
103,300 | $0 | 103,300 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:30 pm |
N/A 2032-05-31 |
Werewolf Therapeutics Inc. | HOWL | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
11,600 | $0 | 11,600 (Indirect) |
View |